INVESTIGACIÓN BÁSICA Y TRASLACIONAL EN ENFERMEDADES INFLAMATORIAS
INVEIN
Charité
Berlín, AlemaniaPublicaciones en colaboración con investigadores/as de Charité (5)
2023
-
2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice
Annals of the Rheumatic Diseases, Vol. 82, Núm. 6, pp. 754-762
-
Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider
RMD Open, Vol. 9, Núm. 1
-
Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider
RMD Open, Vol. 9, Núm. 1
2022
-
2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19
Annals of the rheumatic diseases, Vol. 81, Núm. 1, pp. 34-40
2021
-
EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19
Annals of the Rheumatic Diseases, Vol. 80, Núm. 6, pp. 698-706